不同风险评分在腹主动脉瘤修复中的验证比较
该研究在NIS、VQI和NSQIP三个数据库中验证并比较了Medicare、VSGNE和GAS三种院内死亡风险评分用于择期腹主动脉瘤修复的表现,共纳入NIS 25,461例、VQI 18,588例、NSQIP 8,051例患者。总体而言,VSGNE评分在质量改进登记库中表现最佳但低估死亡率,Medicare评分在开放修复后的行政数据中校准更好。
要点
- VSGNE评分在质量改进登记库中判别与校准优于Medicare和GAS,但低估死亡率。
- Medicare评分在质量改进登记库中倾向于高估死亡率。
- VSGNE评分依赖详细解剖与临床变量,推广至其他数据库受限。
核心结论
- VSGNE评分在质量改进登记库中表现最佳但低估死亡率,Medicare评分在开放修复后的行政数据集中校准更好。
- VSGNE评分对死亡率的估计过于乐观,且依赖详细解剖和临床变量,降低了其推广至其他数据库的适用性。
研究设计与样本
- 回顾性验证研究,纳入2012至2015年在NIS、VQI(排除新英格兰地区)和NSQIP中接受择期开放或腔内腹主动脉瘤修复的患者。
- 共纳入NIS 25,461例、VQI 18,588例、NSQIP 8,051例患者,验证Medicare、VSGNE和GAS三种院内死亡风险评分。
主要发现
- 腔内修复后,Medicare评分在NIS中的AUC高于GAS(P < .001),但与VSGNE评分相比无差异(P = .54)。
- VQI中腔内修复后,VSGNE评分的AUC显著高于Medicare(P < .001)和GAS(P < .001)。
- VSGNE评分在全部三个数据库中校准均优于Medicare评分(P < .001 for all)。
- 开放修复后,NIS中Medicare评分校准优于VSGNE评分(P < .001)。
- VQI中开放修复后,VSGNE评分较Medicare评分判别(P = .008)和校准(P < .001)均显著更好。
临床怎么用
- 选择腹主动脉瘤修复风险评分时需考虑数据来源:质量改进登记库中VSGNE评分判别与校准较优。
- 行政数据集中开放修复后Medicare评分校准更好,应结合数据库类型解读评分结果。
局限性
- VSGNE评分依赖详细解剖和临床变量,限制其向其他数据库推广。
- 研究仅纳入2012至2015年数据,结论的时效性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Accurate and contemporary prognostic risk prediction is essential to inform clinical decision-making surrounding abdominal aortic aneurysm (AAA) care. Therefore, we validated and compared three different in-hospital mortality risk scores in one administrative and two quality improvement registries. METHODS: We included patients who had undergone elective AAA repair from 2012 to 2015 in the National Inpatient Sample (NIS), Vascular Quality Initiative (VQI; excluding the New England region), and the National Surgical Quality Improvement Program (NSQIP) datasets to validate three risk scores: Medicare, the Vascular Study Group of New England (VSGNE), and Glasgow Aneurysm Score (GAS). The receiver operating characteristic area under the curve (AUC) of all risk scores was calculated, and their discrimination was compared within a dataset using the Delong test and between datasets using a Z test. We constructed graphic calibration curves for the Medicare and VSGNE risk scores and compared the calibration using an integrated calibration index, which indicates the weighted average of the absolute difference between the calibration curve and the diagonal line of perfect calibration. RESULTS: We identified a total of 25,461 NIS, 18,588 VQI, and 8051 NSQIP patients who had undergone elective open or endovascular AAA repair. Overall, the Medicare risk score was more likely to overestimate mortality in the quality improvement registries and the VSGNE risk score underestimated mortality in all the databases. After endovascular AAA repair, the Medicare risk score had a higher AUC in the NIS than in the GAS (P < .001) but not compared with the VSGNE risk score (P = .54). The VSGNE risk score was associated with a significantly higher receiver operating characteristic AUC compared with the Medicare (P < .001) and GAS (P < .001) risk scores in the VQI registry. Also, the VSGNE risk score showed improved calibration compared with the Medicare risk score across all three databases (P < .001 for all). After open repair, the Medicare risk score showed improved calibration compared with the VSGNE risk score in the NIS (P < .001). However, in the VQI registry, the VSGNE risk score compared with the Medicare risk score had significantly better discrimination (P = .008) and calibration (P < .001). CONCLUSIONS: Overall, the VSGNE risk score performed best in the quality improvement registries but underestimated mortality. However, the Medicare risk score demonstrated better calibration in the administrative dataset after open repair. Although the VSGNE risk score appeared to perform better in the quality improvement registries, its overly optimistic mortality estimates and its reliance on detailed anatomic and clinical variables reduces its broader applicability to other databases.
引用
- de Guerre LEVM, Dansey KD, Patel PB, et al. Not all risk scores are created equal: A comparison of risk scores for abdominal aortic aneurysm repair in administrative data and quality improvement registries. J Vasc Surg. 2021. PMID: 34302935. doi:10.1016/j.jvs.2021.07.110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。